DM
OREX

Deerfield Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Deerfield Management’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,465
Closed -$152K – 163
2014
Q2 		$152K Buy
+2,465
New +$143K 0.01% 126
2014
Q1 		– Sell
-2,169
Closed -$122K – 157
2013
Q4 		$122K Sell
2,169
-89
-4% -$5K 0.01% 106
2013
Q3 		$138K Hold
2,258
– – 0.01% 113
2013
Q2 		$132K Buy
+2,258
New +$139K 0.01% 114

Other funds holding OREX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deerfield Management's OREX Position: Q3 2014 in Review

Deerfield Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2014, closing a stake of 2,465 shares — an estimated $152K sold.

Deerfield Management first reported a position in OREX in Q2 2013 and held it in 4 quarters. The position peaked at $152K in Q2 2014. 128 funds tracked by Wall St. Rank hold OREX as of Q3 2014.

  • Deerfield Management reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
  • Deerfield Management sold 2,465 Orexigen Therapeutics, Inc. shares in Q3 2014, an estimated $152K.
  • Deerfield Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 4 quarters.
  • Deerfield Management's Orexigen Therapeutics, Inc. position peaked at $152K in Q2 2014.
  • 128 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2014.

Based on Deerfield Management's 13F filing for Q3 2014, filed 14 Nov 2014.